|
Post by dreamboatcruise on Feb 26, 2018 14:03:04 GMT -5
Word of mouth is cheap in the diabetic community. So is that air filled rubber man flapping in the street. Personally, I don't think these clinics can handle a rush of people at the beginning ... so, I wouldn't spend too much on advertising. A few ads would suffice. Did we already confirm that VDex script numbers aren't reported? VDex is just the clinic, they really don't have anything to do with filling scripts. Patients going to see their doctors would still fill scripts through local pharmacies or whatever mail order service their insurance uses. These would be included in Symphony estimates.
|
|
|
Post by casualinvestor on Feb 26, 2018 14:25:15 GMT -5
One of the semi-secret sauce ingredients for VDex is that they have experience working with insurers to get people coverage for Afrezza. So I'd think that most of their long term patients are reported with scripts.
|
|
|
Post by peppy on Feb 26, 2018 14:32:50 GMT -5
One of the semi-secret sauce ingredients for VDex is that they have experience working with insurers to get people coverage for Afrezza. So I'd think that most of their long term patients are reported with scripts. Zueg was vdex, was doing self pay for his underaged son. He got priced out. With insurance, the sky is the limit.
|
|
|
Post by babaoriley on Feb 27, 2018 2:26:45 GMT -5
New Mexico? Huh? Gotta have some serious reservations re that choice?
|
|
|
Post by digger on Feb 27, 2018 21:33:03 GMT -5
One of the semi-secret sauce ingredients for VDex is that they have experience working with insurers to get people coverage for Afrezza. So I'd think that most of their long term patients are reported with scripts. How do you figure that? The owner operates a hair transplant facility and I'm pretty sure that's not covered by insurance.
|
|
|
Post by sportsrancho on Feb 27, 2018 21:37:10 GMT -5
One of the semi-secret sauce ingredients for VDex is that they have experience working with insurers to get people coverage for Afrezza. So I'd think that most of their long term patients are reported with scripts. How do you figure that? The owner operates a hair transplant facility and I'm pretty sure that's not covered by insurance. Rolling on the floor laughing my ass off! oh digger....you have a lot to learn:-)
|
|
|
Post by digger on Feb 27, 2018 22:07:29 GMT -5
How do you figure that? The owner operates a hair transplant facility and I'm pretty sure that's not covered by insurance. Rolling on the floor laughing my ass off! oh digger....you have a lot to learn:-) Such as?
|
|
|
Post by xanet on Mar 2, 2018 12:05:08 GMT -5
Rolling on the floor laughing my ass off! oh digger....you have a lot to learn:-) Such as?Hair transplants are indeed covered, as long as they are medically necessary and not just cosmetic.
|
|
|
Post by zuegirdor on Mar 2, 2018 16:15:49 GMT -5
One of the semi-secret sauce ingredients for VDex is that they have experience working with insurers to get people coverage for Afrezza. So I'd think that most of their long term patients are reported with scripts. Zueg was vdex, was doing self pay for his underaged son. He got priced out. With insurance, the sky is the limit. I should say, priced out of the titration pack. Still using it for corrections, snacks and breakfast. But just got clear to use the coupon (turned 18 today). So we may switch back to titration pack!
|
|
|
Post by zuegirdor on Mar 2, 2018 16:18:28 GMT -5
Rolling on the floor laughing my ass off! oh digger....you have a lot to learn:-) Such as? ...such as never to argue with a diabetic Sicilian when there is blood on the line and a better option than injecting insulin!
|
|
|
Post by sportsrancho on Mar 4, 2018 14:26:10 GMT -5
|
|
|
Post by joeypotsandpans on Mar 4, 2018 15:11:35 GMT -5
Regarding the paper from VDEX, they are spot on regarding the meal and dosing relationship...the Endo I went to suggested I take 8u at mealtime and if still high 1-2hrs after to take a 4u. You can't do a standard regimen like that with everyone especially T2's depending on what else is going on with other meds etc. That is why the real time mgmt. is key with using a sensor unless the T2 is going to stick themselves 20+ times a day. There are days when depending on meals, time of day, and activity I could use anywhere from 16u to 48u (since my prescription avg's out to 48u/day I am conscious of meal selectivity to make sure it balances out). The days I eat closer to a "rabbit diet" I rarely have any spike and use much less. The biggest takeaway is that most individuals that are either pre-diabetic and/or T2's that don't realize it yet or are in denial, given the option would take Afrezza with a much less non-invasive manner of monitoring their BG. Case in point, I recently wrote about the two business associates that claimed they would love to get their dads on it, well one of them I am fairly confident is either going to be a candidate or already is just from the questions he was asking me and answers to some of my questions. He was going to schedule to get his blood work done after our conversation. Another friend of mine recently went back to visit his folks in MN. and his mom is diabetic, she asked him if he has had his blood work checked, he is one that is more in denial I believe but when we were out the night we went to dinner and Spiro joined us you could tell he was very interested in both Afrezza and since has seen my use of the Libre when we've been at lunch. Back on topic with regard to the "non-scientific" white paper, that comment from Mike doesn't surprise me one iota...he is a PharmD and that was the politically correct statement from his training. What he also knows is that physicians are trained and held to work within the realm of what is published professionally and that is why they need the official "studies" to get published. When looking back at the outset of product launch to where we are now, it is blatantly obvious to why the scripts, refills, and salespersons have struggled. With the addition of an extremely credible voice in Kendall, the baby steps of having more/better insurance coverage, the approval of the Libre here in the US, the long elusive pathway to the eventual shift continues to get shorter especially with continued satisfied user experiences being logged and shared. Bottom line, the VDEX paper is worth far more to the patients currently then it is to physicians (as far as their limitations in using it)...having read it, it made me much more confident in my dosing relative to what the Endo had suggested at my first visit and he's been subscribing it pretty much since it's been on the market. I am sure his 8/4 regimen works for some and not so much for others depending on their individual needs...my plan is to wake him up a little bit at my next visit with the stellar results as I'm sure he scratches his head with different results he sees with different patients
|
|
|
Post by peppy on Mar 4, 2018 15:48:44 GMT -5
Regarding the paper from VDEX, they are spot on regarding the meal and dosing relationship...the Endo I went to suggested I take 8u at mealtime and if still high 1-2hrs after to take a 4u. You can't do a standard regimen like that with everyone especially T2's depending on what else is going on with other meds etc. That is why the real time mgmt. is key with using a sensor unless the T2 is going to stick themselves 20+ times a day. There are days when depending on meals, time of day, and activity I could use anywhere from 16u to 48u (since my prescription avg's out to 48u/day I am conscious of meal selectivity to make sure it balances out). The days I eat closer to a "rabbit diet" I rarely have any spike and use much less. The biggest takeaway is that most individuals that are either pre-diabetic and/or T2's that don't realize it yet or are in denial, given the option would take Afrezza with a much less non-invasive manner of monitoring their BG. Case in point, I recently wrote about the two business associates that claimed they would love to get their dads on it, well one of them I am fairly confident is either going to be a candidate or already is just from the questions he was asking me and answers to some of my questions. He was going to schedule to get his blood work done after our conversation. Another friend of mine recently went back to visit his folks in MN. and his mom is diabetic, she asked him if he has had his blood work checked, he is one that is more in denial I believe but when we were out the night we went to dinner and Spiro joined us you could tell he was very interested in both Afrezza and since has seen my use of the Libre when we've been at lunch. Back on topic with regard to the "non-scientific" white paper, that comment from Mike doesn't surprise me one iota...he is a PharmD and that was the politically correct statement from his training. What he also knows is that physicians are trained and held to work within the realm of what is published professionally and that is why they need the official "studies" to get published. When looking back at the outset of product launch to where we are now, it is blatantly obvious to why the scripts, refills, and salespersons have struggled. With the addition of an extremely credible voice in Kendall, the baby steps of having more/better insurance coverage, the approval of the Libre here in the US, the long elusive pathway to the eventual shift continues to get shorter especially with continued satisfied user experiences being logged and shared. Bottom line, the VDEX paper is worth far more to the patients currently then it is to physicians (as far as their limitations in using it)...having read it, it made me much more confident in my dosing relative to what the Endo had suggested at my first visit and he's been subscribing it pretty much since it's been on the market. I am sure his 8/4 regimen works for some and not so much for others depending on their individual needs...my plan is to wake him up a little bit at my next visit with the stellar results as I'm sure he scratches his head with different results he sees with different patients I am so grateful you are here. It sounds like what we want is the vdex dosing regiment. When Mike can, this needs to be the push. Let's see what we get on the stat trial regiment. The stat trial- Patients who are randomized into the TI arm will be instructed to dose before the meals and take necessary corrections at 1- and 2-hours after meals to optimize PPBG (Table 1B). There will be a total of 7 study visits (screening visit, randomization visit, 2 clinic, and 3 phone visits). What we want, we advise with a standard meal to dose Afrezza 15-20 minutes after the start of the meal, and then another dose of the same size about 45 minutes later.With very long meals, we have even advised patients to administer two follow-on doses, for very tight control. The other thing about the vdex paper, no hypoglycemia. Afrezza the insulin you can take. www.seventhform.com/vdexdownloads/vdex-whitepaper-072817.pdfHeh, thanks Joey. Oh additionally, On a facebook Dexcom site, some talk if the difference between Dexcom and Libre. Pointed out to me, libra interstitial. Isn't Dexcom interstitial? (I have some study information and the vdex paper stashed in resources. Thank you Liane.)
|
|
|
Post by sportsrancho on Mar 4, 2018 15:57:23 GMT -5
Google....says: The average meal is 11 minutes long – with some breakfasts and lunches lasting barely 2 minutes. Personally, my breakfast falls into the 2-minute category. Thanks Joey, don’t know what we do without you! www.verywellfit.com/benefits-of-eating-slowly-2223827
|
|
|
Post by peppy on Mar 4, 2018 15:59:57 GMT -5
Google....says: The average meal is 11 minutes long – with some breakfasts and lunches lasting barely 2 minutes. Personally, my breakfast falls into the 2-minute category. Thanks Joey, don’t know what we do without you! Sweetie, your average meals are 11 mins long. I read what you eat. I do not know how you are alive, slim. Yes, I have seen men eat hamburgers in three bites. 11 mins average.
|
|